Roflumilast to Treat Cognitive Sequela After Stroke
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The aim of the current project is to validate the effects of chronic rolflumilast treatment
(12 weeks) on cognitive functions (i.e. episodic memory) by means of behavioral tasks, in
people suffering from cognitive impairments at least 1 year after stroke. Secondarily, the
effects of roflumilast on daily activities and well-being will be assessed.